Apr 28 2018
Insilico Medicine, a Baltimore-based company specializing in the application of next-generation artificial intelligence for drug discovery, biomarker development and aging research, announces the presentation of its CEO, Alex Zhavoronkov, at the Pioneers 18 Conference, May 25, 2018, Vienna, Austria.
Dr. Zhavoronkov's session "Artificial Intelligence for Aging Research" will be devoted to the recent advances in artificial intelligence for human aging research. The presentation will focus on the applications of deep neural networks to the development of new biomarkers of aging.
"We are very happy to present our work at the Pioneers Conference, which gathers the thought leaders in longevity biotechnology and other fields redefining the human tech frontiers. The topic of aging is rapidly gaining popularity and we are happy to be at the leading edge of research and one of the innovation drivers in this area", said Alex Zhavoronkov, PhD, the founder and CEO of Insilico Medicine, Inc.
The Pioneers 18 is a prominent annual conference on deep tech and frontier tech gathering over 2000 bold, pioneering entrepreneurs to look into the future and beyond. The event's organizers aim to establish and facilitate the direct, meaningful business relationships between startups, corporate executives, and investors to foster growth and innovation. The conference will transpire on May 25, 2018.
Source: https://pioneers.io/events/pioneers18#/
Researchers aim to use AI for early screening and prognosis of Dry Eye Disease